BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 22883459)

  • 21. High numbers of human skin cancers express MMP2 and several integrin genes.
    Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
    J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
    Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
    Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
    Yoshino Y; Kageshita T; Nakajima M; Funakubo M; Ihn H
    J Dermatol; 2008 Apr; 35(4):206-14. PubMed ID: 18419677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
    Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
    Määttä M; Santala M; Soini Y; Turpeenniemi-Hujanen T; Talvensaari-Mattila A
    Acta Obstet Gynecol Scand; 2010 Mar; 89(3):380-4. PubMed ID: 20109015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
    Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
    Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
    Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
    Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta].
    Ke Y; Lu JH; Yang BL; Guo HQ; Ma QY; Zhu H; Shu HM; Li DJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):311-4. PubMed ID: 16762185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.